논문KCI 등재
Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
참고문헌 (11)
- Eunji Ko, "Risk factors in nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 29, pp.79~85 (2023), 대한간학회
- Abhijit Pratap, "Letter regarding “Risk factors in nonalcoholic fatty liver disease”", Clinical and Molecular Hepatology, 29(4), pp.1046~1047 (2023), 대한간학회
- Ahn J, "Critical appraisal for lowcarbohydrate diet in nonalcoholic fatty liver disease : Review and meta-analyses", Clin Nutr, 38, pp.2023~2030 (2019)
- Bedogni G, "The Fatty Liver Index : a simple and accurate predictor of hepatic steatosis in the general population", BMC Gastroenterol, 6, pp.33~ (2006)
- Georg Semmler, "Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease", Clinical and Molecular Hepatology, 29, pp.244~260 (2023), 대한간학회
- Erica Jennison, "The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(1), pp.22~43 (2021), 대한간학회[DOI]
- Park WY, "Sugar-sweetened beverage, diet soda, and nonalcoholic fatty liver disease over 6 years : The framingham heart study", Clin Gastroenterol Hepatol, 20, pp.2524~2532 (2022)
- Maersk M, "Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot : a 6-mo randomized intervention study", Am J Clin Nutr, 95, pp.283~289 (2012)
- Theresa J. Hydes, "Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH", Clinical and Molecular Hepatology, 26(4), pp.383~400 (2020), 대한간학회[DOI]
- Kanerva N, "Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults", Am J Clin Nutr, 100, pp.1133~1138 (2014)
- Tsompanaki E, "Systematic review and metaanalysis : The role of diet in the development of nonalcoholic fatty liver disease", Clin Gastroenterol Hepatol, 21, pp.1462~1474 (2023)
관련 논문AI추천
Letter regarding “Risk factors in nonalcoholic fatty liver disease”Abhijit Pratap, Anita Deshmukh, Pradnya Phalak, Umesh More대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제4호Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”김문영, 백순구, Seul Ki Han대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”Hyun Wook Han, Seogsong Jeong, Su Kyoung Lee, Yohwan Lim대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Correspondence to editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunc tion-associated steatotic liver disease”Hye Won Lee, Seung Up Kim대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Correspondence to editorial on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal realworld study”Mindie H. Nguyen, Vy H. Nguyen대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”Dae Won Jun, Eileen L. Yoon대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제1호
이 간행물의 다른 논문 (22건)
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernityJoon Ho Moon, 김원, Gi-Ae Kimpp. 831-843Waiting for the changes after the adoption of steatotic liver disease전대원, Eileen L. Yoonpp. 844-850Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapyTakako Inoue, Yasuhito Tanaka, Takehisa Watanabepp. 851-868Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harmYao-Chun Hsu, Jia-Horng Kao, Cheng-Hao Tsengpp. 869-890Hepatorenal syndrome: Current concepts and future perspectivesChan-Young Jung, Jai Won Changpp. 891-908
